WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 2-Jul-2015 (Data received as of 26-June-2015)
Next overall update Mid July 2015
2014 data are provisional
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 7'0301 Infant (under 12 months) mortality rate: 102
GDP / capita (US$): 15'9411 Child (under 5 years) mortality rate: 122

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 7'168  7'223  7'278  7'333  7'389  8'001  8'821  8'865 
Births 68  69  70  70  71  65  105  133 
Surviving infants 68  69  69  70  70  64  103  130 
Pop. less than 5 years 342  344  345  344  340  330  557  677 
Pop. less than 15 years 992  988  986  984  984  1'254  1'792  1'961 
Female 15-49 years 1'593  1'616  1'639  1'661  1'685  1'936  2'104  2'140 

Number of reported case

(Click for retrospective incidence data for Bulgaria)
Diphtheria
Japanese encephalitis
Measles 14  157  22'004  46  147  10'763 
Mumps 31  25  58  139  317  2'357 
Pertussis 52  89  102  46  54  106  26  154 
Polio* 15 
Rubella 10  18  41  39  28'449 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)** 18 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Bulgaria)
Vaccine year result method % card seen                                                
BCG          97  97  97  98  98  98 
DTP1          90  96  96  96  96  95 
DTP3          88  95  95  95  94  93 
HepB_BD          98  98  98  99  99  98 
HepB3          95  95  95  96  95  94 
Hib3          83  95  95  95  91  90 
JapEnc         
MCV          93  95  94  94  97  89 
MCV2          89  94  94  94  96  83 
PCV1          95  96  95  96  84 
PCV3          92  94  94  94  69 
Pol3          88  95  95  95  94  94 
Rota1         
Rota_last         
Rubella1          93  95  94  94  97 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Bulgaria)
BCG 97  97  98  98  98  99  99 
DTP1 96  96  96  96  95  99  98 
DTP3 95  95  95  94  93  99  98 
HepB3 95  95  96  95  94 
HepB_BD 98  98  99  98  98 
Hib3 95  95  95  91 
MCV 94  94  95  97  89  99  98 
MCV2 94  94  94  96  83 
PCV3 94  94  94  69 
Pol3 95  95  95  94  94  99  99 
Rota_last

Number of districts in the country 28  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 46
From 80 to 89% 36
From 50 to 79% 18
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG Birth; 7 months; 7, 11, 17 years; Yes after Manntoux test negative
DTaPHibHepIPV 2, 3, 4 months; Yes
DTaPHibIPV 2, 3, 4, 16 months; Yes
DTaPIPV 6 years; Yes
HepB Birth; 1, 6 months; Yes
Influenza_Adult Yes elderly, adults with chronic diseases, health care workers, and other risk groups
Influenza_Pediatric Yes children with chronic diseases
MMR 13 months; 12 years; Yes
Pneumo_conj 2, 3, 4, 12 months; Yes
Rabies Yes As post-exposure prophylaxis
Td 12, 17, 25, 35, 45, 55 years; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  No  No  No  Yes  No  No 
What years does the MYP cover? number         2005-2010  2005-2010   
Nº of districts with microplans that include activities to raise immunization coverage number 28  28  28  28  28  28  28 

System performance

Total Nº districts in country number 28  28  28  28  28  28  28 
Nº districts with DTP3 coverage >=80% number 23  28  28  28  27  27  28 
% of districts with DTP3 coverage >=80% From 0 to 100% 82  100  100  100  96  96  100 
Nº districts with measles (MCV1) coverage >=95% number 14  16  13  13  19  28  17 
% of districts with MCV1 coverage >=95% From 0 to 100% 50  57  46  46  68  100  61 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100%     100  100  100    100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.